BioPharmSignal logoBioPharmSignal

Biotech News

ClearPoint Neuro Reports First Quarter 2026 Results

ClearPoint Neuro (CLPT)ClearPoint NeuroEarnings

CLPT (CLPT) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is clpt.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

CLPTClearPoint Neuro2026-08-03 20:05 EST

ClearPoint Neuro Reports Second Quarter 2026 Results

CLPTClearPoint Neuro2026-07-21 20:05 EST

ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026

SHCSotera Health2026-08-06 11:00 EST

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

HYPRHyperfine2026-08-06 20:05 EST

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

DNLIDenali Therapeutics2026-08-06 20:01 EST

Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

OMOutset Medical2026-08-06 20:01 EST

Outset Medical Reports Second Quarter 2026 Results

HYPRHyperfine2026-07-23 20:05 EST

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

OMOutset Medical2026-07-23 13:00 EST

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

TMCITreace Medical Concepts2026-08-07 11:05 EST

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

View all latest news

ClearPoint Neuro

Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine. ClearPoint Navigation The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics. Cell...

Recent company news

CLPTClearPoint Neuro2026-08-03 20:05 EST

ClearPoint Neuro Reports Second Quarter 2026 Results

CLPTClearPoint Neuro2026-07-31 20:05 EST

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel

CLPTClearPoint Neuro2026-07-21 20:05 EST

ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026

CLPTClearPoint Neuro2026-05-27 20:30 EST

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

CLPTClearPoint Neuro2026-05-13 20:05 EST

ClearPoint Neuro Reports First Quarter 2026 Results

Stock data

Close
13.39 USD
Market cap
370.97M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States